0
0The paper introduces Fragmentia-AI, a novel artificial intelligence framework designed to detect cancer by analyzing the "language" of cell-free DNA (cfDNA). Unlike traditional methods that focus on rare genetic mutations, this large language model identifies structural patterns and fragmentation signatures within DNA sequences to differentiate between healthy and malignant samples. This approach allows for highly accurate cancer detection using ultra-low sequencing depth, significantly reducing costs while maintaining effectiveness across seventeen different cancer types. Research demonstrates that the model successfully identifies cancer signals even in mutation-negative cases and effectively monitors post-treatment risks. By leveraging multiple instance learning and attention-based mechanisms, the system isolates tumor-derived signals from a minimal amount of data. Ultimately, the authors present a scalable and generalized solution for liquid biopsy that supports early diagnosis and clinical monitoring.
References:
Xu Y, Bao H, Huang D, et al. Toward generalizable prediction of cancer signal using a cell-free DNA language model[J]. Cell Reports Medicine, 2026.
